CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: Involvement of SH2-containing phosphotyrosine phosphatase SHP-1

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 2903-2912

  Perez Villar, Juan J ^a   Whitney, Gena S ^a   Bowen, Michael A ^a   Hewgill, Derek H ^a   Aruffo, Alejandro A ^a   Kanner, Steven B ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD5 ANTIGEN; PHENYLALANINE; PHOSPHOLIPASE C; PHYTOHEMAGGLUTININ; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE RECEPTOR; TYROSINE;

ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0032936299     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.4.2903     Document Type: Article

References (52)

1. Alberola-Ila, J., L. Places, F. Lozano, and J. Vives. 1993. Association of an activation inducible serine kinase activity with CD5. J. Immunol. 151:4423-4430.
2. Aruffo, A., M. A. Bowen, D. D. Patel, B. F. Haynes, G. C. Starling, J. A. Gebe, and J. Bajorath. 1997. CD6-ligand interactions: a paradigm for SRCR domain function? Immunol. Today 18:498-504.
3. Biaconte, L., M. A. Bowen, A. Lim, A. Aruffo, G. Andres, and I. Stamenkovic. 1996. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J. Exp. Med. 184:811-819.
4. Bikah, G., J. Carey, J. R. Ciallella, A. Tarakhovsky, and S. Bondada. 1996. CD5-mediated negative regulation of antigen receptor-induced growth signal in B-1 cells. Science 274:1906-1909.
5. Bowen, M. A., G. S. Whitney, M. Neubauer, G. C. Starling, D. Palmer, J. Zhang, N. J. Nowak, T. B. Shows, and A. Aruffo. 1996. Structural and chromosomal location of the human CD6 gene: detection of five human isoforms. J. Immunol. 158:1149-1156.
6. Burgess, K. E., M. Yamamoto, K. V. S. Prasad, and C. E. Rudd. 1992. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor ζ chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proc. Natl. Acad. Sci. USA 89:9311-9315.
7. Casali, P., S. E. Burastero, M. Nakamura, G. Inghirami, and A. L. Notkins. 1987. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to the Leu-1 + B cell subset. Science 236:77-81.
8. Cerutti, A., L. Trentin, R. Zambello, R. Sancetta, A. Milani, C. Tassinari, F. Adami, C. Agostini, and G. Semenzato. 1996. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J. Immunol. 157:1854-1862.
9. Ceuppens, J. L., and M. L. Baroja. 1986. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase bound OKT3. J. Immunol. 137:1816-1821.
10. Cyster, J. G., and C. C. Goodenow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2:13-24.
11. Cornall, R. J., J. C. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodenow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497-508.
12. D'Ambrosio, D., K. L. Hippen, S. A. Minskoff, I. Mellman, G. Pani, K. A. Siminovitch, and J. C. Cambier. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gammaRIIB1. Science 268:293-297.
13. Davies, A. A., S. C. Ley, and M. J. Crumpton. 1992. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 89:6368-6372.
14. Dennehy, K. M., R. Broszeit, D. Garnett, G. A. Durrheim, L. L. Spruyt, and A. D. Beyers. 1997. Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5. Eur. J. Immunol. 27:679-686.
15. Doody, G. M., L. B. Justement, C. C. Delibrias, R. J. Matthews, J. Lin, M. L. Thomas, and D. T. Fearon. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242-244.
16. Huang, H. J. S., N. H. Jones, J. L. Strominger, and L. A. Herzenberg. 1987. Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to the human counterpart Leu-1/T1 (CD5). Proc. Natl. Acad. Sci. USA 84:204-208.
17. Jones, N. H., M. L. Clabby, D. P. Dialynas, H. J. S. Huang, L. A. Herzenberg, and J. L. Strominger. 1986. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. Nature 323:346-349.
18. June, C. H., P. S. Ravinovitch, and J. A. Ledbetter. 1987. CD5 antibodies increase intracellular ionized calcium concentration in T cells. J. Immunol. 138:2782-2792.
19. Kanner, S. B., N. K. Damle, J. Blake, A. A. Aruffo, and J. A. Ledbetter. 1992. CD2/LFA3 ligation induces phospholipase-Cγ1 tyrosine phosphorylation and regulates CD3 signaling. J. Immunol. 148:2023-2029.
20. Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 80:729-738.
21. Kodama, T., L. Freeman, J. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger. 1990. Type 1 macrophage scavenger receptor contains alpha helical and collagen-like coiled coils. Nature 343:531-535.
22. Kozlowski, M., I. Mlinaric-Rascan, G. S. Feng, R. Shen, T. Pawson, and K. A. Siminovitch. 1993. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178:2157-2163.
23. Lanier, L. L. 1998. Natural killer receptors. Annu. Rev. Immunol. 16:359-393.
24. Lankester, A. C., G. M. van Schijndel, J. L. Cordell, C. J. van Noesel, and R. A. van Lier. 1994. CD5 is associated with the human B cell antigen receptor complex. Eur. J. Immunol. 24:812-816.
25. Ledbetter, J. A., C. H. June, L. S. Grosmaire, and P. S. Rabinovitch. 1987. Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc. Natl. Acad. Sci. USA 84:1384-1388.
26. Ledbetter, J. A., C. H. June, P. J. Martin, C. E. Spooner, J. A. Hansen, and K. E. Meier. 1986. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation. J. Immunol. 136:3945-3952.
27. Lorenz, U., K. S. Ravichandran, S. F. Burakoff, and B. J. Neel. 1996. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc. Natl. Acad. Sci. USA 93:9624-9629.
28. Luo, W., H. van de Velde, I. von Hoegen, J. R. Parnes, and K. Thielemans. 1992. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). J. Immunol. 148:1630-1634.
29. Migone, T. S., N. A. Cacalano, N. Taylor, T. Yi, T. A. Waldmann, and J. A. Johnston. 1998. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor: loss of SHP-1 expression in human T-lymphotropic virus type I-transformed cells. Proc. Natl. Acad. Sci. USA 95:3845-3850.
30. Neel, B. G. 1997. Role of phosphatases in lymphocyte activation. Curr. Opin. Immunol. 9:405-420.
31. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 275:798-801.
32. Osman, N., S. C. Ley, and M. J. Crumpton. 1992. Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes. Eur. J. Immunol. 22:2995-3000.
33. Otipoby, K. L., K. B. Andersson, K. E. Draves, S. J. Klaus, A. G. Farr, J. D. Kenner, R. M. Perlmutter, C.-L. Law, and E. A. Clark. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384:634-637.
34. Pani, G., K.-D. Fischer, I. Mlinaric-Rascan, and K. A. Siminovitch. 1996. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184:839-852.
35. Plas, D. R., R. Johnson, J. T. Pingel, R. J. Matthews, M. Dalton, G. Roy, A. C. Chan, and M. L. Thomas. 1996. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science 272:1173-1176.
36. Plater-Zyberk, C., P. C. Taylor, M. G. Blaylock, and R. N. Maini. 1994. Anti-CD5 therapy decreases severity of established disease in collagen type II-induced arthritis in DBA/1 mice. Clin. Exp. Immunol. 98:442-447.
37. lck. Mol. Cell. Biol. 14:2862-2870.
38. Rincon, M., M. Cebrian, F. Sanchez-Madrid, and M. Lopez-Botet. 1989. Induction of T cell function via the gp33/27 activation inducer molecule (AIM) requires co-expression of the CD3/TcR complex. Eur. J. Immunol. 19:959-962.
39. Sato, S., A. S. Miller, M. Inaoki, C. B. Bock, P. J. Jansen, M. L. Tang, and T. F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling on CD22-deficient mice. Immunity 5:551-562.
40. Secrist, J. P., L. A. Burns, L. Karnitz, G. A. Koretzky, and R. T. Abraham. 1993. Stimulatory effect of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268:5886-5893.
41. Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. Yi, J. N. Ihle, R. J. Matthews, M. L. Thomas, and D. R. Beier. 1993. Mutations at the murine motheaten locus are within the haematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-1454.
42. Spertini, F., W. Stohl, N. Ramesh, C. Moody, and R. S. Geha. 1991. Induction of human T cell proliferation by a monoclonal antibody to CD5. J. Immunol. 146:47-52.
43. Starling, G. C., G. S. Whitney, A. W. Siadak, M. C. Llewellyn, M. A. Bowen, A. G. Farr, and A. Aruffo. 1996. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Eur. J. Immunol. 26:738-746.
44. Sun, D., K. Branum, and Q. Sun. 1992. Prevention of experimental autoimmune encephalomyelitis in Lewis rats by treatment with an anti-rat CD5 antibody (OX19). Cell. Immunol. 145:263-271.
45. Tarakhovsky, A., S. B. Kanner, J. Hombach, J. A. Ledbetter, W. Muller, N. Killeen, and K. Rajewsky. 1995. A role for CD5 in TcR-mediated signal transduction and thymocyte selection. Science 269:535-537.
46. Timms, J. F., D. Carlberg, H. Gu, H. Chen, S. Kamatkar, M. J. Nadler, L. R. Rohrscheider, and B. G. Neel. 1998. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol. Cell. Biol. 18:3838-3850.
47. Tsui, H. W., K. A. Siminovitch, L. de Souza, and F. W. Tsui. 1993. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4:124-129.
48. Tuskano, J., P. Engel, T. F. Tedder, and J. H. Kehrl. 1996. Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation. Blood 87:4723-4730.
49. Tuskano, J. M., P. Engel, T. F. Tedder, A. Argarwa, and J. H. Kehrl. 1996. Involvement of p72 syk kinase, p53/56 lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur. J. Immunol. 26:1246-1252.
50. Unkeless, J. C., and J. Lin. 1997. Inhibitory receptors, ITIM sequences and phosphatases. Curr. Top. Immunol. 9:338-343.
51. Van de Velde, H., I. von Hoegen, W. Luo, J. R. Parnes, and K. Thielemans. 1991. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351:662-665.
52. Yi, T., A. L. Mui, G. Krystal, and J. N. Ihle. 1993. Hemopoietic cell phosphatase associates with the interleukin (IL-3) receptor B chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol. Cell. Biol. 13:7577-7586.